“Trend in precrisptions of antidepressants and anxiolytics in the fist year of the COVID-19 pandemic”, RBM, vol. 28, no. 2, p. e-20252263, Jan. 2025, doi: 10.25061/2527-2675/ReBraM/2025.v28i2.2263.